Article
Harnessing preclinical mouse models to inform human clinical cancer trials
23 Mar 2006
Abstract excerpt
The urgent need for better cancer treatments has stimulated interest in employing small-animal models to evaluate potential drug therapies. Robust mouse models of many human cancers have been generated using sophisticated technologies for engineering germ-line mutations. As we enter into an age of targeted therapeutics, these strains provide novel platforms for validating new anticancer drugs, assessing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
